Published in Endocr Pract on April 11, 2011
Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism. Ann Surg Treat Res (2015) 0.85
Lower vitamin D levels in surgical hyperparathyroidism versus thyroid patients. Am Surg (2014) 0.76
Validation of the "Perrier" parathyroid adenoma location nomenclature. World J Surg (2012) 0.75
Surgical treatment of primary hyperparathyroidism due to parathyroid tumor: A 15-year experience. Oncol Lett (2016) 0.75
Same-day discharge after unilateral parathyroidectomy is safe. Can J Surg (2016) 0.75
Use of the gamma probe to identify multigland disease in primary hyperparathyroidism. Int J Endocr Oncol (2016) 0.75
Patterns of disease in patients at a tertiary referral centre requiring reoperative parathyroidectomy. Ann R Coll Surg Engl (2015) 0.75
Intraoperative PTH May Not Be Necessary in the Management of Primary Hyperparathyroidism Even with Only One Positive or Only Indeterminate Preoperative Localization Studies. World J Surg (2017) 0.75
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med (2012) 7.06
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA (2013) 5.71
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract (2006) 4.62
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
⁸²Rb PET myocardial perfusion imaging is superior to ⁹⁹mTc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging (2012) 2.23
The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract (2009) 2.14
A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid (2010) 1.68
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer (2006) 1.56
Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors. J Am Coll Cardiol (2012) 1.49
Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res (2004) 1.47
American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract (2009) 1.44
The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol (2014) 1.43
Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med (2007) 1.41
BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J Clin Endocrinol Metab (2012) 1.39
Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med (2010) 1.38
Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res (2003) 1.36
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res (2012) 1.28
A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid (2008) 1.27
Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res (2004) 1.21
A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med (2013) 1.19
Beyond the suspicious thyroid fine needle aspirate. A review. Acta Cytol (2003) 1.18
Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery (2008) 1.15
Postoperative hypocalcemia after thyroidectomy for Graves' disease. Thyroid (2010) 1.12
Radiation dosimetry of 82Rb in humans under pharmacologic stress. J Nucl Med (2011) 1.06
Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol (2011) 1.05
Molecular pathogenesis of thyroid cancer. Surg Oncol (2003) 1.05
Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res (2008) 1.05
Bilateral plasmacytoma of the breast: a case report. Breast J (2002) 1.04
Absolute myocardial flow quantification with (82)Rb PET/CT: comparison of different software packages and methods. Eur J Nucl Med Mol Imaging (2013) 1.03
DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther (2010) 1.02
Differentiated thyroid cancer. Semin Oncol (2010) 1.02
A multi-institutional international study of risk factors for hematoma after thyroidectomy. Surgery (2013) 0.99
Predictive factors of malignancy in pediatric thyroid nodules. Surgery (2011) 0.97
Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid (2012) 0.95
Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer? Surgery (2012) 0.94
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. Thyroid (2008) 0.92
Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury. J Nucl Med (2010) 0.91
Chasing "shadows": discovering the subtleties of sestamibi scans to facilitate minimally invasive parathyroidectomy. World J Surg (2011) 0.91
Thyroid tumorigenesis and molecular markers in thyroid cancer. Curr Opin Oncol (2010) 0.91
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl Med Commun (2005) 0.89
A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Surgery (2005) 0.89
The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol (2010) 0.87
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab (2013) 0.87
Tumor size and presence of calcifications on ultrasonography are pre-operative predictors of lymph node metastases in patients with papillary thyroid cancer. J Surg Oncol (2011) 0.86
The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology. J Surg Oncol (2012) 0.85
Three-gene molecular diagnostic model for thyroid cancer. Thyroid (2012) 0.85
Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery (2004) 0.84
Solitary fibrous tumor of the thyroid: cytopathologic findings and differential diagnosis. Diagn Cytopathol (2003) 0.84
Preoperative thyroid ultrasound is indicated in patients undergoing parathyroidectomy for primary hyperparathyroidism. J Cancer (2011) 0.84
The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules. J Surg Oncol (2011) 0.84
A tertiary center's experience with second review of 3885 thyroid cytopathology specimens. J Clin Endocrinol Metab (2013) 0.83
Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocr Pract (2004) 0.83
Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res (2004) 0.83
Coronary artery and thoracic aorta calcification is inversely related to coronary flow reserve as measured by ⁸²Rb PET/CT in intermediate risk patients. J Nucl Cardiol (2013) 0.82
Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker. J Nucl Med (2012) 0.82
Telomere length is related to alternative splice patterns of telomerase in thyroid tumors. Am J Pathol (2011) 0.82
Cardiac PET/CT misregistration causes significant changes in estimated myocardial blood flow. J Nucl Med (2012) 0.82
The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma. Surgery (2013) 0.82
Intrathyroidal parathyroid glands: small, but mighty (a Napoleon phenomenon). Surgery (2012) 0.81
The heart in obesity-hypertension. Expert Rev Cardiovasc Ther (2005) 0.81
Laparoscopic resection of a paraganglioma of the organ of Zuckerkandl in a patient with a carotid body tumor. Am Surg (2006) 0.80
Evolution in the surgical management of well-differentiated thyroid cancer or not: to dissect or not dissect the central lymph node compartment. J Surg Oncol (2010) 0.79
Unusual case of metastatic neuroendocrine tumor. Endocr Pract (2007) 0.79
25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery (2005) 0.79
Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies. J Nucl Med (2012) 0.78
Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg (2012) 0.77
Initial human experience with Rubidium-82 renal PET/CT imaging. J Med Imaging Radiat Oncol (2013) 0.77
BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol (2013) 0.77
African Americans present with more severe primary hyperparathyroidism than non-African Americans. Surgery (2008) 0.77
Lower vitamin D levels in surgical hyperparathyroidism versus thyroid patients. Am Surg (2014) 0.76
An unusual case of recurrent hyperparathyroidism and papillary thyroid cancer. Endocr Pract (2009) 0.76
Translational research in surgical disease. Arch Surg (2010) 0.76
Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with The Bethesda System for Reporting Thyroid Cytopathology. Acta Cytol (2015) 0.76
BRAF pyrosequencing analysis aided by a lookup table. Am J Clin Pathol (2014) 0.76
Hypertrophic obstructive cardiomyopathy in liver transplant patients. Cardiol J (2008) 0.76
Is there an increased risk of second primary malignancy after diagnosis of thyroid cancer? Cancer (2014) 0.75
Good question. Surgery (2011) 0.75
Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol (2017) 0.75
Clinical presentation of patients with a thyroid follicular neoplasm: are there preoperative predictors of malignancy? Ann Surg Oncol (2015) 0.75
The role of telomeres and telomerase in endocrine tumors. Discov Med (2010) 0.75
Serendipity in the diagnosis of pheochromocytoma. J Comput Assist Tomogr (2013) 0.75
How do liquid-based preparations of thyroid fine-needle aspiration compare with conventional smears? An analysis of 5475 specimens. Thyroid (2015) 0.75
The death of an Indian Rhinoceros. World J Surg (2010) 0.75
Modern approaches to age-old questions about thyroid tumors. Thyroid (2005) 0.75
Genomic medicine for cancer prognosis. J Surg Oncol (2014) 0.75
Computed Tomography in the Management of Adrenal Tumors: Does Size Still Matter? J Comput Assist Tomogr (2017) 0.75